BlackRock Institutional Trust’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.27M Buy
119,847
+11,522
+11% +$221K ﹤0.01% 3006
2016
Q3
$2.4M Hold
108,325
﹤0.01% 2979
2016
Q2
$1.98M Buy
108,325
+15,351
+17% +$264K ﹤0.01% 3041
2016
Q1
$1.69M Sell
92,974
-1,810
-2% -$29.3K ﹤0.01% 3106
2015
Q4
$1.6M Buy
94,784
+8,292
+10% +$141K ﹤0.01% 3198
2015
Q3
$1.56M Buy
86,492
+28,672
+50% +$639K ﹤0.01% 3199
2015
Q2
$1.5M Buy
57,820
+15,518
+37% +$392K ﹤0.01% 3230
2015
Q1
$926K Buy
+42,302
New +$913K ﹤0.01% 3364

Other funds holding ENTL

BlackRock Institutional Trust's ENTL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Entellus Medical, Inc. Common Stock (ENTL) stake by 11% in Q4 2016, buying an estimated $221K and bringing the position to 119,847 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3006.

BlackRock Institutional Trust first reported a position in ENTL in Q1 2015 and has held it in 8 quarters since. The position peaked at $2.4M in Q3 2016. 63 funds tracked by Wall St. Rank hold ENTL as of Q4 2016.

  • BlackRock Institutional Trust held 119,847 shares of Entellus Medical, Inc. Common Stock worth $2.27M as of Q4 2016.
  • BlackRock Institutional Trust bought 11,522 Entellus Medical, Inc. Common Stock shares in Q4 2016, an estimated $221K.
  • Entellus Medical, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3006 holding.
  • BlackRock Institutional Trust first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Institutional Trust's Entellus Medical, Inc. Common Stock position peaked at $2.4M in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.